Cargando…
Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298497/ https://www.ncbi.nlm.nih.gov/pubmed/32585589 http://dx.doi.org/10.1016/j.ejca.2020.06.004 |
_version_ | 1783547218615074816 |
---|---|
author | Souza, Ive L. Fernandes, Ítalo Taranto, Patrícia Buzaid, Antonio C. Schvartsman, Gustavo |
author_facet | Souza, Ive L. Fernandes, Ítalo Taranto, Patrícia Buzaid, Antonio C. Schvartsman, Gustavo |
author_sort | Souza, Ive L. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7298497 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72984972020-06-17 Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic Souza, Ive L. Fernandes, Ítalo Taranto, Patrícia Buzaid, Antonio C. Schvartsman, Gustavo Eur J Cancer Letter to the Editor Elsevier Ltd. 2020-08 2020-06-17 /pmc/articles/PMC7298497/ /pubmed/32585589 http://dx.doi.org/10.1016/j.ejca.2020.06.004 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Souza, Ive L. Fernandes, Ítalo Taranto, Patrícia Buzaid, Antonio C. Schvartsman, Gustavo Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic |
title | Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic |
title_full | Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic |
title_fullStr | Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic |
title_full_unstemmed | Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic |
title_short | Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic |
title_sort | immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (covid-19) pandemic |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298497/ https://www.ncbi.nlm.nih.gov/pubmed/32585589 http://dx.doi.org/10.1016/j.ejca.2020.06.004 |
work_keys_str_mv | AT souzaivel immunerelatedpneumonitiswithnivolumabandipilimumabduringthecoronavirusdisease2019covid19pandemic AT fernandesitalo immunerelatedpneumonitiswithnivolumabandipilimumabduringthecoronavirusdisease2019covid19pandemic AT tarantopatricia immunerelatedpneumonitiswithnivolumabandipilimumabduringthecoronavirusdisease2019covid19pandemic AT buzaidantonioc immunerelatedpneumonitiswithnivolumabandipilimumabduringthecoronavirusdisease2019covid19pandemic AT schvartsmangustavo immunerelatedpneumonitiswithnivolumabandipilimumabduringthecoronavirusdisease2019covid19pandemic |